ArticleCurrent microbiology2025
Assessing the Role of Myxobacteria Isolates in the Biotransformation of Flavoring Substances.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Myxobacteria are well known for producing secondary metabolites with various potential applications, including volatile compounds that serve as flavors, although this capability is less documented. This study characterizes the morphology of six Myxococcus strains (InaCC B1497, B1482, B1498, B1483, B1484, and B1486) obtained from the Indonesian Culture Collection (InaCC) and evaluates their potential for flavor biotransformation. Morphological observations were conducted on fruiting bodies, vegetative cells, myxospores, and colony shapes using dissection and binocular microscopes. All strains were identified as Myxococcus with 99% similarity to Myxococcus stipitatus DSM14675T based on 16S rRNA gene sequencing. Strains InaCC B1484 and B1486 demonstrated the ability to convert geraniol into various terpenes and hydrocarbons, with strain B1486 producing high levels of citral and geranyl oleate, while B1484 yielded significant amounts of geranial and nerol. Both isolates also showed capability for limonene conversion, with B1486 displaying a broader range of aromatic hydrocarbons. Draft genome sequences for strains InaCC B1484 and B1486, each approximately 10.75 Mbp, revealed 99.99% ANI (average nucleotide identity) with each other and 89.5% ANI with the reference genome Myxococcus stipitatus DSM14675T. Both genomes contain genes associated with terpenoid and polyketide biosynthesis, including pathways for geraniol and limonene degradation.
Indexed as
Identifiers
40029366What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.